NICE Recommends First Subcutaneous Option for Haemophilia B ...Middle East

Medscape - News
NICE Recommends First Subcutaneous Option for Haemophilia B
The recommendation of marstacimab (Hympavzi) for severe haemophilia B offers the first subcutaneous treatment and potential relief for over 200 eligible patients in England. Medscape News UK

Read More Details
Finally We wish PressBee provided you with enough information of ( NICE Recommends First Subcutaneous Option for Haemophilia B )

Also on site :



Latest News